Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Baxter
Covington
US Army
McKesson
Accenture
Citi
Fuji
Teva

Generated: January 21, 2018

DrugPatentWatch Database Preview

VIOXX Drug Profile

« Back to Dashboard

Which patents cover Vioxx, and when can generic versions of Vioxx launch?

Vioxx is a drug marketed by Merck and is included in two NDAs. There is one patent protecting this drug.

This drug has thirty-seven patent family members in thirty-one countries.

The generic ingredient in VIOXX is rofecoxib. There are two drug master file entries for this compound. Additional details are available on the rofecoxib profile page.
Summary for VIOXX
International Patents:37
US Patents:1
Applicants:1
NDAs:2
Bulk Api Vendors: 80
Patent Applications: 4,915
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VIOXX at DailyMed
Drug patent expirations by year for VIOXX

US Patents and Regulatory Information for VIOXX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck VIOXX rofecoxib SUSPENSION;ORAL 021052-001 May 20, 1999 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-002 May 20, 1999 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Merck VIOXX rofecoxib SUSPENSION;ORAL 021052-002 May 20, 1999 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-001 May 20, 1999 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-003 Feb 25, 2000 DISCN No No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for VIOXX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck VIOXX rofecoxib SUSPENSION;ORAL 021052-002 May 20, 1999 ➤ Subscribe ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-001 May 20, 1999 ➤ Subscribe ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-003 Feb 25, 2000 ➤ Subscribe ➤ Subscribe
Merck VIOXX rofecoxib SUSPENSION;ORAL 021052-001 May 20, 1999 ➤ Subscribe ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-003 Feb 25, 2000 ➤ Subscribe ➤ Subscribe
Merck VIOXX rofecoxib SUSPENSION;ORAL 021052-002 May 20, 1999 ➤ Subscribe ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-002 May 20, 1999 ➤ Subscribe ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-002 May 20, 1999 ➤ Subscribe ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-001 May 20, 1999 ➤ Subscribe ➤ Subscribe
Merck VIOXX rofecoxib TABLET;ORAL 021042-002 May 20, 1999 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for VIOXX

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Mallinckrodt
Cerilliant
Chubb
Fuji
Express Scripts
Harvard Business School
Deloitte
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot